Erchonia® EVRL™
Sponsors
Erchonia Corporation
Conditions
NeuropathyNeuropathy, DiabeticNeuropathy, PainfulNeuropathy;PeripheralTMDTMJTMJ Pain
Unknown Phase
Clinical Efficacy and Human Factors Validation Testing of the Erchonia EVRL for Providing Temporary Relief of Diabetic Peripheral Neuropathy Foot Pain
CompletedNCT05291975
Start: 2022-02-17End: 2024-12-12Updated: 2025-08-13
Clinical Efficacy of the Erchonia EVRL for Providing Temporary Relief of Idiopathic Peripheral Neuropathy Foot Pain
RecruitingNCT06912646
Start: 2025-05-01End: 2027-06-16Target: 32Updated: 2025-09-08
A Double-blind, Placebo-controlled Evaluation of the Effect of the Erchonia® EVRL on Chronic Jaw Pain Arising From TMJ
RecruitingNCT07600203
Start: 2026-05-14End: 2027-12-22Target: 64Updated: 2026-05-20